The convergence of nanotechnology and neuroscience holds promise for the successful development of external electronic devices capable of interfacing with the central nervous system (CNS). In recent years, considerable progress has been made in the fabrication of electronic devices at the micro- and nano-scales. However, it remains to be discovered how biological components can be successfully integrated with these devices. The long-term goal of our research project is to develop a series of hybrid neural prosthetic devices, consisting of biological components with digital integration that will allow the simultaneous measurement, and stimulation, of neural events in the CNS. The central hypothesis of this application is that the integration of biological components with neural prosthetic devices, will promote their successful integration with the mammalian CNS, to enhance long-term device performance. We will use research strategies from a variety of disciplines, including neuroscience, nanotechnology, computer sciences and engineering to accomplish our goals.
The specific aims of this project are to: (i) develop methodologies for the design and construction of hybrid neural prosthetic devices; and, (ii) assess the functionality of hybrid devices in both in vitro and in vivo settings. The rationale for these studies is that, once we can reliably integrate biological components with neural prosthetic devices, that these basic design features will permit the construction of devices with additional biological units each of which possesses greater complexity. The research design is to use primary cultures of hippocampal pyramidal neurons as the biological components. Neurons will be incorporated with prosthetic devices, using a novel bio-mimetic polymer. The integration of hybrid devices into the CNS will be described using electrophysiological, pharmacological, and morphological methods. We envisage that end stage prosthetic devices will contain both organic and electrical components for providing inputs, controlling network function, and recording outputs. Presently 5.3 million Americans - approximately 2% of the U.S. population - live with disabilities resulting from a traumatic brain injury. The development of hybrid neural prosthetic devices will have the potential to restore function to people who suffer from a diverse range of neurological disabilities. ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Biomedical Imaging and Bioengineering (NIBIB)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21EB007782-02
Application #
7492817
Study Section
Special Emphasis Panel (ZRG1-MDCN-K (50))
Program Officer
Peng, Grace
Project Start
2007-09-01
Project End
2009-07-31
Budget Start
2008-08-01
Budget End
2009-07-31
Support Year
2
Fiscal Year
2008
Total Cost
$197,275
Indirect Cost
Name
Wadsworth Center
Department
Type
DUNS #
153695478
City
Menands
State
NY
Country
United States
Zip Code
12204
Smith, Karen L; Herron, Bruce; Dowell-Mesfin, Natalie et al. (2012) Knockdown of cortical transthyretin expression around implanted neural prosthetic devices using intraventricular siRNA injection in the brain. J Neurosci Methods 203:398-406
Frampton, John P; Hynd, Matthew R; Shuler, Michael L et al. (2010) Effects of glial cells on electrode impedance recorded from neuralprosthetic devices in vitro. Ann Biomed Eng 38:1031-47
Jun, Sang Beom; Smith, Karen L; Shain, William et al. (2010) Optical monitoring of neural networks evoked by focal electrical stimulation on microelectrode arrays using FM dyes. Med Biol Eng Comput 48:933-40
Jun, Sang Beom; Hynd, Matthew R; Dowell-Mesfin, Natalie M et al. (2008) Modulation of cultured neural networks using neurotrophin release from hydrogel-coated microelectrode arrays. J Neural Eng 5:203-13
Frampton, John P; Shuler, Michael L; Shain, William et al. (2008) Biomedical Technologies for in vitro Screening and Controlled Delivery of Neuroactive Compounds. Cent Nerv Syst Agents Med Chem 8:203-219
Hynd, Matthew R; Frampton, John P; Dowell-Mesfin, Natalie et al. (2007) Directed cell growth on protein-functionalized hydrogel surfaces. J Neurosci Methods 162:255-63